Daiichi Sankyo, Inc. and American Regent, Inc., a Daiichi Sankyo Group company, have announced that the U.S. Food and Drug Administration (FDA) approved INJECTAFER (ferric carboxymaltose injection) for the treatment of iron deficiency in adult patients with heart failure.
June 06, 2023
FDA Approves Intravenous Iron Replacement Therapy for Heart Failure Patients
June 6, 2023 — Daiichi Sankyo, Inc. and American Regent, Inc., a Daiichi Sankyo Group company, have announced that the…
Read More
According to a news release issued by the U.S. Food and Drug Administration (FDA), Abiomed has recalled specific Impella 5.5 with SmartAssist for purge fluid leaks that can cause pump stop and loss of support. The FDA has identified this as a Class I recall, the most serious type of recall. Use of these devices may cause serious injuries or death.
June 06, 2023
Abiomed Recalls Specific Impella 5.5 with SmartAssist for Purge Fluid Leaks that Can Cause Pump Stop and Loss of Support
June 6, 2023 — According to a news release issued by the U.S. Food and Drug Administration (FDA), Abiomed has recalled…
Read More
The 2023 Multimodality Appropriate Use Criteria (AUC) for the Detection and Risk Assessment of Chronic Coronary Disease is now available online. The new document updates the 2013 AUC and includes several shifts in terminology.
June 05, 2023
Societies Update Multimodality AUC: SPECT and PET Appropriate for Many Patients
June 5, 2023 — The 2023 Multimodality Appropriate Use Criteria (AUC) for the Detection and Risk Assessment of Chronic…
Read More
INPEFA reduced the risk of total occurrence of cardiovascular death, hospitalization for heart failure, and urgent heart failure visits by 33% compared to placebo in the SOLOIST-WHF study
June 05, 2023
Lexicon Announces FDA Approval of INPEFA (Sotagliflozin) for Treatment of Heart Failure
June 5, 2023 —  Lexicon Pharmaceuticals, Inc.  announced that the U.S. Food and Drug Administration (FDA) has approved …
Read More
Long-Awaited Data Published in JAMA Confirms Minimally Invasive Procedure for Degenerative Mitral Regurgitation Is Successful in Nearly 90% of Patients
June 05, 2023
Study: Transcatheter Mitral Valve Repair Safe, Successful
June 5, 2023 —  Long-awaited outcomes data of transcatheter edge-to-edge procedures to repair patients’ leaky mitral…
Read More
Medtronic has announced its appointment of Ken Washington, Ph.D., to the newly-created role of Senior Vice President, Chief Technology and Innovation Officer.
June 05, 2023
Medtronic Appoints Former Amazon Exec to New Chief Technology and Innovation Officer Role
June 5, 2023 — Medtronic has announced its appointment of Ken Washington, Ph.D., to the newly-created role of Senior…
Read More
Drs. Jerome Rotter & Matt Budoff study shows that in middle-aged to older adults the coronary artery calcium score improved CHD risk discrimination
June 02, 2023
Lundquist Institute Investigators Co-author Paper in JAMA on Coronary Heart Disease (CHD) Risk Prediction
June 2, 2023 — The Lundquist Institute (TLI) announced today that Jerome Rotter, MD, and Matthew Budoff, MD, two of TLI…
Read More
XenoSim project will establish the new field of ‘computational cardiac xenotransplantation’ and establish pioneering computational techniques with significant implications for a range of scientific disciplines
June 02, 2023
University College Dublin Researcher Receives ERC Funding to Unlock Insights Into Pig-to-human Heart Transplants
June 2, 2023 — Dr. Philip Cardiff, Associate Professor at University College Dublin's School of Mechanical and…
Read More
University of Cincinnati stroke researchers present at international conference
June 02, 2023
Study Finds Distinct Patterns of Pre-existing Brain Health Characteristics in Stroke Patients
June 2, 2023 — University of Cincinnatiresearchers presented abstracts at the European Stroke Organization Conference(…
Read More
International consortium led by Amsterdam UMC has now delivered an improved verson of the innovative pacemaker
June 01, 2023
Leadless Pacemakers Soon Available for All Patients
June 1, 2023 — Every year more than one million people receive a pacemaker. Until now, leadless versions were only…
Read More
Analysis of TWILIGHT trial shines light on Effect of Therapies following percutaneous coronary intervention
June 01, 2023
Ticogrelor Monotherapy Post PCI Associated with Similar Rates of Revascularization as Duel Antiplatelet Therapy
June 1, 2023 — New insights from the TWILIGHT trial showed that ticagrelor monotherapy after three months of ticagrelor…
Read More
ACC Care of the Athletic Heart highlights latest advances in the field of sports cardiology
June 01, 2023
American College of Cardiology to Host Sports Cardiology Conference
June 1, 2023 — The American College of Cardiology will host the annual Care of the Athletic Heart course on June 8-10,…
Read More
Here's a look at what viewers found most interesting during the month of May on DIcardiology.com
By Melinda Taschetta-Millane
June 01, 2023
Top 10: A Look at What Caught Your Eye in May
It's been a fruitful month for DIcardiology.com! Here's a look at what DAIC viewers found to be most interesting during…
Read More
Rechargeable multi-parameter wearable patch enables continuous and real time monitoring of remote patients
May 31, 2023
Vivalink Releases 14-Day Live Stream Wearable ECG Patch for Ambulatory Cardiac Monitoring
May 31, 2023 — Vivalink, a leading provider of digital healthcare solutions, is announcing the newest version of its…
Read More
There are currently no FDA approved treatments for PH-HFpEF, a condition affecting more than 1,600,000 North Americans, with estimates indicating a prevalence of more than 2,000,000 patients by 2030
May 31, 2023
Tenax Therapeutics Achieves Major Milestone as USPTO Grants Notice of Allowance for U.S. Patent Application Covering Use of Oral Levosimendan (TNX-103) in PH-HFpEF
May 31, 2023 — Tenax Therapeutics, Inc., a specialty pharmaceutical company focused on identifying, developing and…
Read More
Cytomegalovirus (CMV) is one of the most prevalent herpesviruses worldwide.
May 31, 2023
People Coinfected with SARS-CoV-2 and Cytomegalovirus are at Increased Risk of Developing Cardiovascular Disease
May 31, 2023 — Cytomegalovirus (CMV) is one of the most prevalent herpesviruses worldwide. Depending on the…
Read More
A new report, “Digital Transformation in Healthcare Market,” from Future Market Insights, Inc., found that by the end of 2023, the fast-paced sector is expected to be worth $65.2 billion.
May 31, 2023
Healthcare Digital Transformation Market Report Forecasts Major Growth thru 2033
May 31, 2023 — A new report is shedding light on the fast pace of growth in the digital heath sector at present and…
Read More
May 31, 2023
Impacts of Chronic Stress on Cardiovascular Disease Risk to be Focus of American Heart Association (AHA) $15 Million Research Project
May 31, 2023 — The American Heart Association (AHA) has announced that teams of research scientists from three…
Read More
The objective of this study was to assess the safety and efficacy of SELUTION SLR, MedAlliance’s novel sirolimus-eluting balloon, for endovascular therapy of de novo and non-stented restenotic lesions in the superficial femoral artery (SFA) and popliteal artery (PA).
May 30, 2023
Excellent 12-Month Results from SELUTION SFA Trial Presented at JET
May 30, 2023 — Twelve-month results from the SELUTION SFA trial have been presented for the first time at the Japan …
Read More
MagicTouch PTA -Sirolimus Coated Balloon has recently received IDE approval from the US FDA for SFA indication
May 30, 2023
Concept Medical’s fourth IDE approval for the MagicTouch Sirolimus Coated Balloon is granted for the treatment of Superficial Femoral Artery Disease (SFA)
May 30, 2023 — The US FDA, on the 24th of May 2023, granted an Investigational Device Exemption (IDE) approval for …
Read More
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now